332 related articles for article (PubMed ID: 22799032)
1. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
[TBL] [Abstract][Full Text] [Related]
2. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
Wang J; Xu Y; Wen C; Wang Z
Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
[TBL] [Abstract][Full Text] [Related]
3. [Identification of related substances in rifampicin by HPLC-DAD spectroscopy correlation].
Li W; Hu CQ; Jin SH
Yao Xue Xue Bao; 2007 Dec; 42(12):1292-7. PubMed ID: 18338643
[TBL] [Abstract][Full Text] [Related]
4. Spectral correlation of high-performance liquid chromatography-diode array detection data from two independent chromatographic runs peak tracking in pharmaceutical impurity profiling.
Li W; Hu CQ
J Chromatogr A; 2008 May; 1190(1-2):141-9. PubMed ID: 18374928
[TBL] [Abstract][Full Text] [Related]
5. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
6. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
Xu Y; Wang D; Zhu B; Tang L; Wang J
J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
[TBL] [Abstract][Full Text] [Related]
8. Structural identification and characterization of impurities in ceftizoxime sodium.
Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
[TBL] [Abstract][Full Text] [Related]
9. [Rapid identification of the isomeric impurity in raw drug of cefepime dihydrochloride by liquid chromatography-tandem mass spectrometry].
Zhao L; Guo JF; Zhang AJ; Zhao YM
Yao Xue Xue Bao; 2005 Apr; 40(4):361-4. PubMed ID: 16011268
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of cephalosporin antibiotics using 0.3 mm I.D. columns.
Moore CM; Sato K; Katsumata Y
J Chromatogr; 1991 Feb; 539(1):215-20. PubMed ID: 2013613
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the impurities and isomers in cefetamet pivoxil hydrochloride by liquid chromatography/time-of-flight mass spectrometry and ion trap mass spectrometry.
Wang D; Wang F; Wang J
J Pharm Biomed Anal; 2015; 111():71-7. PubMed ID: 25863019
[TBL] [Abstract][Full Text] [Related]
12. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
Prajapati KJ; Kothari CS
Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
[TBL] [Abstract][Full Text] [Related]
13. Determination and quantification of related substances and degradation products in bictegravir by full factorial design evaluated HPLC and mass spectrometry.
Kumar SRJ; Rao VK; Katari NK; Jyothi NS; Kowtharapu LP
Anal Methods; 2023 Mar; 15(10):1274-1285. PubMed ID: 36852477
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the polymerized impurities in cefmetazole sodium based on novel separation principle by liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
Wang F; Ren X; Zhu B; Zhang F; Gao J; Hong L; Wang J
J Pharm Biomed Anal; 2022 Jun; 215():114790. PubMed ID: 35483231
[TBL] [Abstract][Full Text] [Related]
15. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
[TBL] [Abstract][Full Text] [Related]
16. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
17. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
Ermer J; Vogel M
Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
[TBL] [Abstract][Full Text] [Related]
18. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
[TBL] [Abstract][Full Text] [Related]
19. A digitized impurity database analysis method for determining the impurity profiles of gatifloxacin in bulk materials and injections.
Dousheng Z; Yan C; Yaping L; Shangchen Y; Changqin H
Pharmazie; 2012 Oct; 67(10):827-33. PubMed ID: 23136715
[TBL] [Abstract][Full Text] [Related]
20. Quantitative impurity profiling by principal component analysis of high-performance liquid chromatography-diode array detection data.
Wiberg K
J Chromatogr A; 2006 Mar; 1108(1):50-67. PubMed ID: 16430906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
